Meiji Holdings Co Ltd
TSE:2269
Gross Margin
Meiji Holdings Co Ltd
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| JP |
|
Meiji Holdings Co Ltd
TSE:2269
|
897.7B JPY |
29%
|
|
| JP |
G
|
Goyo Foods Industry Co Ltd
TSE:2230
|
53.2T JPY |
34%
|
|
| CH |
|
Nestle SA
SIX:NESN
|
232.2B CHF |
47%
|
|
| US |
|
Mondelez International Inc
NASDAQ:MDLZ
|
89.2B USD |
39%
|
|
| FR |
|
Danone SA
PAR:BN
|
45.6B EUR |
50%
|
|
| ZA |
T
|
Tiger Brands Ltd
JSE:TBS
|
42.7B Zac |
28%
|
|
| US |
|
Kraft Heinz Co
NASDAQ:KHC
|
36.1B USD |
35%
|
|
| US |
|
Hershey Co
NYSE:HSY
|
34.4B USD |
47%
|
|
| US |
|
General Mills Inc
NYSE:GIS
|
32.4B USD |
35%
|
|
| CN |
|
Foshan Haitian Flavouring and Food Co Ltd
SSE:603288
|
227.3B CNY |
35%
|
|
| CH |
|
Chocoladefabriken Lindt & Spruengli AG
SIX:LISN
|
26.6B CHF |
65%
|
Meiji Holdings Co Ltd
Glance View
Meiji Holdings Co., Ltd. has long been a staple in the world of Japanese consumer goods, specifically in the food and pharmaceutical sectors. Established in 2009 as a result of merging Meiji Seika Kaisha, Ltd. and Meiji Dairies Corporation, the company stands as a testament to the power of strategic consolidation, leveraging over a century of expertise from its predecessors. The company's robust product portfolio spans a diverse array of offerings, including dairy products like yogurts and milk, confectioneries like chocolate and candy, as well as nutrition bars and supplements. This triumvirate of product lines allows Meiji Holdings to position itself in both the everyday consumer market and in specialized health-centric industries, exploiting economies of scale and extensive distribution networks that reach far beyond the Japanese archipelago. In the pharmaceutical arena, Meiji Holdings operates under its subsidiary, Meiji Seika Pharma, focusing predominantly on antibacterial drugs, central nervous system treatments, and veterinary products. By integrating research and development with a comprehensive marketing strategy, the company capitalizes on global health trends and regional disease challenges, expanding in markets that emphasize health and dietary improvements. Financially, Meiji Holdings generates revenue by producing goods that tap into both traditional consumer desires and modern nutritional trends. It makes money by introducing high-margin pharmaceutical innovations alongside its well-established consumer brands, thus benefiting from both everyday sales and solutions aimed at pressing global health needs. Together, these strategic components make Meiji Holdings an agile player in a competitive global market, combining heritage with innovation.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Meiji Holdings Co Ltd's most recent financial statements, the company has Gross Margin of 29.4%.
You don't have any saved screeners yet